glutathione and triple negative breast cancer Metabolic interplay between exogenous cystine glutamine dependence in triple-negative Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



